Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

About Karius

Karius is tracked on 100Xfounder as a biotech company, founded in 2014, based in San Francisco Bay Area, California, USA, currently mapped to the Series B stage. Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Profile snapshot: Founders linked: Karius Team. Funding tracked: $165.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

  • Karius appears in the 100Xfounder startup directory import feed.

Why it Matters

Karius is worth tracking because its funding history is already mapped here, including a $165.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Karius Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $165.00MLast Round: Series B Khosla Ventures, $165M Series B in 2020All Rounds: 1
  • Series B | Khosla Ventures, $165M Series B in 2020

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: June 1, 2026

Karius research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

  • Founders covered

    Karius Team

  • Market position

    Biotech | Series B | San Francisco Bay Area, California, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $165.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Biotech with comparable market signals.

Discover Now

Newsroom and topic pages connected to Karius.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Karius

Common questions people ask about this profile.

What is Karius?

Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare

Who founded Karius?

Karius is associated with Karius Team on 100Xfounder.

Where is Karius located?

Karius is listed in San Francisco Bay Area, California, USA.

What stage is Karius in?

Karius is currently mapped to Series B. Funding context: Khosla Ventures, $165M Series B in 2020

What is the latest funding round of Karius?

Karius's latest tracked round is Series B Khosla Ventures, $165M Series B in 2020. Total tracked rounds: 1.

Is Karius hiring now?

Karius hiring status: Open Roles.

What technologies does Karius use?

Karius is associated with AWS, React, Python, and PostgreSQL.

Is Karius verified on 100Xfounder?

Yes. Karius is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with Karius founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.